Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Hansen, Morten L., Sørensen, Rikke, Clausen, Mette T., Fog-Petersen, Marie Louise, Raunsø, Jakob, Gadsbøll, Niels, Gislason, Gunnar H., Folke, Fredrik +6 more·2010·Archives of Internal Medicine
DOI 10.1001/archinternmed.2010.271

Cited by (853)

Items 301–400 of 853

  1. Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel.
    M. Rohla, T. Weiss, J. Wojta, A. Niessner, K. Huber · 2015 · European Heart Journal - Cardiovascular Pharmacotherapy
  2. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial
    Antonia Sambola, José Bruno Montoro Ronsano, Bruno García del Blanco, Nadia Llavero, José A. Barrabés, Fernándo Alfonso, Héctor Bueno, Angel R. Cequier, Antonio Serra, Javier Zueco et al. · 2013 · American Heart Journal
  3. Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis
    Dylan E. Stanger, Alym Abdulla, Frank T. Wong, Sina Alipour, Brian L. Bressler, David Alexander Wood, John G. Webb · 2016 · Catheterization and Cardiovascular Interventions
  4. Stroke Prevention in Atrial Fibrillation
    Christos Voukalis, Eduard Shantsila, Gregory Y.H. Lip · 2017 · The Journal of the Royal College of Physicians of Edinburgh
  5. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
    David Kopin, W. Schuyler Jones, Matthew William Sherwood, DANIEL M. WOJDYLA, Lars C. Wallentin, Basil S. Lewis, Freek W.A. Verheugt, Dragoş Vinereanu, Maria Cecilia Bahit, Sigrun Halvorsen et al. · 2017 · American Heart Journal
  6. Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry.
    Rungroj Krittayaphong, Arintaya Phrommintikul, Pornchai Ngamjanyaporn, Khanchai Siriwattana, Wiwat Kanjanarutjawiwat, Thoranis Chantrarat, Roj Rojjarekampai, Pontawee Kaewcomdee, Patthrapon Sonkhammee · 2019 · PubMed Central
  7. Long-term antithrombotic therapy after venous stent placement
    Chenyu Lin, Karlyn A. Martin, Mei Wang, Brady Lee Stein, Kush R Desai · 2019 · Phlebology The Journal of Venous Disease
  8. Current aspects of TIA management
    Benjamin G. Clissold, Thanh G. Phan, John V Ly, Shaloo Singhal, Velandai K. Srikanth, Henry Ma · 2020 · Journal of Clinical Neuroscience
  9. Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants
    Luciane Cruz Lopes, Frederick Alan Spencer, Ignacio Neumann, Matthew Ventresca, Shanil Ebrahim, Qi Xin Zhou, Neera Bhatnagar, Sam Schulman, John W. Eikelboom, Gordon Henry Guyatt · 2014 · PLoS ONE
  10. Comparison of Anticoagulant Therapy for Atrial Fibrillation - Novel Oral Anticoagulants Versus Vitamin K Antagonists
    Sean T. Chen, Manesh R. Patel · 2018 · Progress in Cardiovascular Diseases
  11. Refining Antithrombotic Therapy for Atrial Fibrillation and Acute Coronary Syndromes or PCI
    Shamir R. Mehta · 2019 · New England Journal of Medicine
  12. Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events
    Romain Chopard, Guillaume Serzian, S. Humbert, Nicolas Falvo, Mathilde Morel-Aleton, Benjamin Bonnet, Gabriel Napporn, Elsa Kalbacher, Laurent Obert, Bruno Degano et al. · 2018 · Journal of Thrombosis and Thrombolysis
  13. The Management of Patients on Oral Anticoagulation Undergoing Coronary Stent Implantation: A Survey among Interventional Cardiologists from Eight European Countries
    Andrea Rubboli, Willem Dewilde, Kurt Huber, Éric Eeckhout, István Herzfeld, JOSÈ VALENCIA, Stephan Windecker, Juhani K.E. Airaksinen, Gregory Y.H. Lip · 2011 · Journal of Interventional Cardiology
  14. Stroke risk stratification scores in atrial fibrillation: current recommendations for clinical practice and future perspectives
    Joseph Durrant, Gregory Y.H. Lip, Deirdre A. Lane · 2012 · Expert Review of Cardiovascular Therapy
  15. Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    T. Hoshi, A. Sato, A. Nogami, M. Gosho, K. Aonuma · 2017 · Journal of Cardiology
  16. Aspirin-omitted dual antithrombotic therapy in non-valvular atrial fibrillation patients presenting with acute coronary syndrome or undergoing percutaneous coronary intervention: results of a meta-analysis
    Cheng-Feng Luo, Pei Mo, Guoqiang Li, Shiming Liu · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  17. Contemporary Reflections on the Safety of Long-Term Aspirin Treatment for the Secondary Prevention of Cardiovascular Disease
    Alexander C. Fanaroff, Matthew T. Roe · 2016 · Drug Safety
  18. Why do Geriatric Patients Visit Otorhinolaryngology?
    Gül Soylu Özler, Erhan Yengil · 2016 · Ear Nose & Throat Journal
  19. Medication adherence trajectories and clinical outcomes in patients with cardiovascular disease: a systematic review and meta-analysis
    Qianzi Hou, Yuhan Zhao, Ying Wu · 2025 · Journal of Global Health
  20. Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion
    Joon‐Tae Kim, Ji Sung Lee, Beom Joon Kim, Jong‐Moo Park, Kyusik Kang, Soo Joo Lee, Jae Guk Kim, Jae‐Kwan Cha, Dae-Hyun Kim, Tai Hwan Park et al. · 2020 · Translational Stroke Research
  21. Choice and Duration of Anticoagulation for Venous Thromboembolism
    Geoffrey D. Barnes, Aroosa Malik, Nghi B. Ha · 2024 · Journal of Clinical Medicine
  22. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting
    Grant William Reed, Christopher Paul Cannon · 2013 · Clinical Cardiology
  23. Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis
    Fernando Javier Vázquez, Joaquín P. Gonzalez, Grégoire Le Gal, Marc Carrier, Esteban Gándara · 2015 · Thrombosis Research
  24. Emerging Tools for Stroke Prevention in Atrial Fibrillation
    Christos Voukalis, Gregory Y.H. Lip, Eduard Shantsila · 2016 · EBioMedicine
  25. Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes
    Hannah Sinclair, Vijay Kunadian · 2016 · Heart
  26. Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination
    Hazem Fathy Elewa, Dina Ahmed, Geoffrey D. Barnes · 2016 · Seminars in Thrombosis and Hemostasis
  27. Predictors of gastrointestinal bleeding in older persons taking nonsteroidal anti-inflammatory drugs: Results from the FDA adverse events reporting system
    Deborah Dillon McDonald · 2019 · Journal of the American Association of Nurse Practitioners
  28. Etiologies of Intracerebral Hematomas
    Qingliang T. Wang, Stanley Tuhrim · 2012 · Current Atherosclerosis Reports
  29. Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention – real life assessment
    Paweł Bogacki, Anna Kabłak-Ziembicka, Krzysztof L. Bryniarski, Leszek Wrotniak, Elżbieta Ostrowska-Kaim, Krzysztof F. Zmudka, Tadeusz Przewłocki · 2016 · Advances in Interventional Cardiology
  30. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
    Wolfgang Fischbach, Jan Bornschein, Jörg Hoffmann, Sibylle Koletzko, Alexander Link, Lukas Macke, Peter Malfertheiner, Kerstin Schütte, Dieter-Michael Selgrad, Sebastian Suerbaum et al. · 2024 · Zeitschrift für Gastroenterologie
  31. Balancing between bleeding and thromboembolism after percutaneous coronary intervention in patients with atrial fibrillation. Could triple anticoagulant therapy be a solution?
    Magdalena Dąbrowska, Andrzej J. Ochala, Wiesław Cybulski, Michał Tendera · 2013 · Advances in Interventional Cardiology
  32. Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case–control studies
    Kathrin Jobski, Falk Hoffmann, Stefan Herget‐Rosenthal, Michael Dörks · 2019 · Clinical Research in Cardiology
  33. Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach.
    Ali Ali, Claire Bailey, Ahmed H. Abdelhafiz · 2012 · Europe PMC (PubMed Central)
  34. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy
    Inna Tzoran, Benjamin Brenner, Gleb Sakharov, Javier Trujillo‐Santos, Alicia Lorenzo, Olga Madridano, J.B. López‐Sáez, Manuel Monréal · 2014 · European Journal of Internal Medicine
  35. Left ventricular apical aneurysm following primary percutaneous coronary intervention
    Masayuki Mori, Kenichi Sakakura, Hiroshi Wada, Nahoko Ikeda, Hiroyuki Jinnouchi, Yoshitaka Sugawara, Norifumi Kubo, Shin‐ichi Momomura, Junya Ako · 2012 · Heart and Vessels
  36. Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study)
    Gilles Lemesle, Guillaume Schurtz, Thibaud Meurice, Olivier Tricot, Nestor Lemaire, Sébastien Caudmont, André Philias, Régis Ketelers, Nicolas Lamblin, Christophe Bauters · 2016 · Cardiology
  37. Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants
    Pier Paolo Bocchino, Filippo Angelini, Elisabetta Toso · 2021 · Reviews in Cardiovascular Medicine
  38. Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction
    Youngjoong Kim, Joohan Lim, Jonggu Lim, Soohyun Kim, Tae-Young Jung, Woong‐Gil Choi · 2013 · Korean Circulation Journal
  39. Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease
    Xavier Humbert, Vincent Roule, Mathieu Chequel, Sophie Fédrizzi, Marie Brionne, Véronique Lelong‐Boulouard, Paul Milliez, Joachim Alexandre · 2016 · International Journal of Cardiology
  40. Impact of quality of anticoagulation control on outcomes in patients with atrial fibrillation taking aspirin: An analysis from the SPORTIF trials
    Marco Proietti, Gregory Y.H. Lip · 2017 · International Journal of Cardiology
  41. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
    Freek W.A. Verheugt, Giuseppe Ambrosio, Dan Atar, Jean‐Pierre Bassand, A. John Camm, Juan Pablo Costabel, David Andrew Fitzmaurice, Laura Illingworth, Samuel Zachary Goldhaber, Shinya Goto et al. · 2019 · The American Journal of Medicine
  42. Impact of Antithrombotic Agents on Postpancreatectomy Hemorrhage: Results from a Retrospective Multicenter Study
    Kota Nakamura, Masayuki Sho, Sohei Satoi, Hisashi Kosaka, Takahiro Akahori, Minako Nagai, Kenji Nakagawa, Tadataka Takagi, Tomohisa Yamamoto, So Yamaki · 2020 · Journal of the American College of Surgeons
  43. Coronary Stent Implantation in Patients Committed to Long-term Oral Anticoagulation Therapy
    Andrea Rubboli, Jason Ciril Kovacic, Roxana Mehran, Gregory Y.H. Lip · 2011 · CHEST Journal
  44. Effects of oral anticoagulant therapy in patients with pulmonary diseases
    Jiying Lai, Shenghui Feng, Shuo Xu, Xin Liu · 2022 · Frontiers in Cardiovascular Medicine
  45. Mechanical valve thrombosis: Current management and differences between guidelines
    Adela Mihaela Șerban, Dana Elena Gavan, Diana Pepine, Alexandra Dǎdârlat, Raluca Tomoaia, Stefan Dan Cezar Mot, Alexandru Achim · 2023 · Trends in Cardiovascular Medicine
  46. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study
    Xudong Liu, Xuxian Lv, Yanfang Peng, Jianing Wang, Junjie Lei, Chaogang Tang, Shijian Luo, Weihua Mai, Yiming Cai, Qian Fan et al. · 2024 · BMC Neurology
  47. Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit
    Stephanie M. Meller, Andreas Baumbach, Szilárd Vörös, Michael J. Mullen, Alexandra J. Lansky · 2013 · BMC Medicine
  48. Antiagregación doble frente a simple, con o sin anticoagulación, tras reemplazo percutáneo de válvula aórtica: comparación indirecta y metanálisis
    Monica Verdoia, Lucia Barbieri, Matteo Nardin, Harry Suryapranata, Giuseppe De Luca · 2017 · Revista Española de Cardiología
  49. Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes
    Matthew Ian Worthley · 2010 · Patient Related Outcome Measures
  50. Anticoagulation Needs in Asians with Atrial Fibrillation: A Mythbuster
    Zeenathnisa Mougammadou Aribou, Adrian Mondry · 2014 · Annals of the Academy of Medicine Singapore
  51. Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians
    JoAnne Micale Foody · 2017 · Clinical Interventions in Aging
  52. Non-vitamin K Antagonist Oral Anticoagulant After Acute Coronary Syndrome: Is There a Role?
    Paul Guedeney, Birgit Vogel, Roxana Mehran · 2018 · Interventional Cardiology Reviews Research Resources
  53. Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II
    Taku Inohara, Peter Shrader, Karen S. Pieper, Rosalia G Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard John Gersh, Alan S. Go, Michael D. Ezekowitz, Peter Russell Kowey et al. · 2019 · American Heart Journal
  54. Advancements in hemostatic strategies for managing upper gastrointestinal bleeding: A comprehensive review
    Ah Young Lee, Joo Young Cho · 2024 · World Journal of Gastroenterology
  55. Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis
    Xiaoxuan Gong, Shaowen Tang, Jiangjin Li, Xiwen Zhang, Xiaoyi Tian, Shuren Ma · 2017 · PLoS ONE
  56. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
    Jerome Ment · 2015 · Vascular Health and Risk Management
  57. A Phase II, double‐blind, randomized, parallel group, dose‐finding study of the safety and tolerability of darexaban compared with warfarin in patients with non‐valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL‐2)
    Gregory Y.H. Lip, Jonathan L. Halperin, P. Petersen, George M. Rodgers, Dénes Páll, Ronny W. Renfurm · 2015 · Journal of Thrombosis and Haemostasis
  58. Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
    Andrea L. Schaffer, Michael O. Falster, David B. Brieger, Louisa R. Jorm, Andrew Wilson, Melanie Hay, Kira Leeb, Sallie‐Anne Pearson, Arthur Nasis · 2019 · Journal of the American Heart Association
  59. Guidelines for mono, double and triple antithrombotic therapy
    Renate C. A. E. van Uden, I. Houtenbos, A. Griffioen-Keijzer, Diego A. M. Odekerken, P. Van Den Bemt, M. Becker · 2021 · Postgraduate medical journal
  60. ST-Segment Elevation Myocardial Infarction
    Jonathan R. Enriquez, James A. de Lemos · 2013 · Springer eBooks
  61. A Review of Oral Anticoagulants in Patients with Atrial Fibrillation
    Arnold J. Greenspon · 2012 · Postgraduate Medicine
  62. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study
    Tobias Dreischulte, Karen N Barnett, Vishnu B. Madhok, Bruce Guthrie · 2013 · European Journal of General Practice
  63. Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry
    Eiichi Watanabe, Mayumi Yamamoto, Itsuo Kodama, Hiroshi Inoue, Hirotsugu Atarashi, Ken Okumura, Takeshi Yamashita, Gregory Y.H. Lip, Eitaro Kodani, Yuji Okuyama et al. · 2016 · International Journal of Cardiology
  64. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions
    N. Faza, A. Mentias, Akhil Parashar, P. Chaudhury, Amr F. Barakat, S. Agarwal, Siddharth A. Wayangankar, S. Ellis, E. Tuzcu, Samir R. Kapadia · 2017 · Catheterization and cardiovascular interventions
  65. Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction
    Christoph Liebetrau, Luise Gaede, Jan Sebastian Wolter, Julia Homann, Alexander Meyer, Oliver Dörr, HOLGER M. NEF, Christian Troidl, Christian W. Hamm, Helge Möllmann et al. · 2016 · Biomarkers
  66. Effectiveness and safety of drugs used for stroke prevention in a cohort of non‐valvular atrial fibrillation patients from a primary care electronic database
    Maria Giner‐Soriano, Albert Roso‐Llorach, Cristina Vedia Urgell, Xavier Castells Cervelló, Dolors Capellà, Ignacio Ferreira González, Josep Maria Elorza, Marc Casajuana‐Closas, Amelia Troncoso‐Mariño, Eduard Diogène et al. · 2016 · Pharmacoepidemiology and Drug Safety
  67. Management of neurologic complications of coagulopathies
    Joshua D. VanDerWerf, Monisha A. Kumar · 2017 · Handbook of clinical neurology
  68. N-Acetyl Cysteine Prevents Arterial Thrombosis in a Dose-Dependent Manner In Vitro and in Mice
    Christopher A. Bresette, Katrina J. Ashworth, Jorge Di Paola, David N. Ku · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
  69. Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial
    Ashley Verburg, Willem L. Bor, I. Tarik Küçük, Josè P.S. Henriques, Maarten A. Vink, Willem-Peter T. Ruifrok, Jacobus Plomp, Ton A.C.M. Heestermans, Carl E. Schotborgh, Pieter J. J. Vlaar et al. · 2024 · EuroIntervention
  70. Atrial Fibrillation
    Michael D. Ezekowitz, Timothy H. Aikens, Rangadham Nagarakanti, Timothy Alan Shapiro · 2011 · Circulation
  71. Antithrombotic Therapy for Atrial Fibrillation and Coronary Disease Demystified
    Jason G. Andrade, Marc William Deyell, Graham Christopher Wong, Laurent Macle · 2018 · Canadian Journal of Cardiology
  72. Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
    Dimitrios Venetsanos, Mikolaj Skibniewski, Magnus Janzon, Sofia Sederholm Lawesson, Emmanouil Charitakis, Felix Böhm, Loghman Henareh, Pontus Andell, Lars Karlsson, Moa Simonsson et al. · 2021 · JACC: Cardiovascular Interventions
  73. Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight
    Francesca Bodega, Anita Russi, Francesco Melillo, Fabiana Blunda, Claudia Rubino, Giulio Leo, Alberto Maria Cappelletti, Patrizio Mazzone, Paolo Mattiello, Paolo Emilio Della Bella et al. · 2021 · European Journal of Clinical Investigation
  74. Patients with atrial fibrillation undergoing percutaneous coronary intervention: current concepts and concerns: part II.
    M. Dzeshka, Richard A. Brown, G. Lip · 2014 · Polskie Archiwum Medycyny Wewnetrznej
  75. Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation
    Giacomo Zoppellaro, Serena Granziera, Seena Padayattil Jose, Gentian Denas, Alessia Bracco, Sabino Iliceto, Vittorio Pengo · 2015 · Expert Opinion on Drug Safety
  76. The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio
    Apostolοs Safouris, Nikos I. Triantafyllou, John Parissis, Georgios K. Tsivgoulis · 2015 · Therapeutic Advances in Neurological Disorders
  77. Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry
    Dawid Leander Staudacher, Michael Kaiser, Christoph Hehrlein, Christoph Bode, Ingo Ahrens · 2015 · PLoS ONE
  78. Management of Stroke Risk in Atrial Fibrillation Patients with Bleeding on Oral Anticoagulation Therapy-Role of Left Atrial Appendage Closure, Octreotide and more.
    Dhanunjaya Lakkireddy · 2017 · Journal of Atrial Fibrillation
  79. New Techniques to Control Gastrointestinal Bleeding.
    Edward Yang, Michael A Chang, Thomas J. Savides · 2019 · PubMed Central
  80. Expert Recommendations on the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) from India: Current Perspective and Future Direction
    Balbir Bagicha Singh, Paresh Pai, Harish Kumar, Sheeba George, Sandeep Mahapatra, Vineet Garg, G. N. Gupta, Kiran Makineni, Gaurav Ganeshwala, Pravin Narkhede et al. · 2022 · Cardiology and Therapy
  81. Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants
    Yutao Guo, Gregory Y.H. Lip, Stavros Z. Apostolakis · 2013 · Hospital Practice
  82. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention
    Christoph B. Olivier, Jun Fan, Mariam Askari, Kenneth W. Mahaffey, Paul A. Heidenreich, Alexander C. Perino, George C. Leef, P. Michael Ho, Robert A. Harrington, Mintu P. Turakhia · 2019 · Circulation Cardiovascular Interventions
  83. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation
    Gregory Y.H. Lip · 2015 · Expert Review of Cardiovascular Therapy
  84. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
    Marco Valgimigli, Alessandro Spirito, Samantha Sartori, Dominick Joseph Angiolillo, Pascal Vranckx, José M. de la Torre Hernández, Mitchell W. Krucoff, Sripal Bangalore, Deepak L. Bhatt, Gianluca Calogero Campo et al. · 2023 · JACC: Cardiovascular Interventions
  85. Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran
    Christian Weimar, Stefan Hans Hohnloser, John W. Eikelboom, Hans‐Christoph Diener · 2011 · Current Neurology and Neuroscience Reports
  86. Contra: “New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation”
    Josef Finsterer, Claudia Stöllberger · 2013 · Thrombosis and Haemostasis
  87. Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome)
    Henri M.H. Spronk, Suzanne C. Cannegieter, Pierre‐Emmanuel Morange, Tilman M. Hackeng, Menno Volkert Huisman, Michael Nagler, Jelle J. Posthuma, Marisa Ninivaggi, Suzanne Zwaveling, Tom van der Hulle et al. · 2015 · Thrombosis Research
  88. Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role
    Dimitrios K. Alexopoulos, Panagiotis K. Vlachakis, John P Lekakis · 2017 · Cardiovascular Drugs and Therapy
  89. Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics
    Prasad S. Nishtala, Hamish A. Jamieson, Hugh Carl Hanger, Te‐yuan Chyou, Sarah Nicole Hilmer · 2019 · Cardiovascular Drugs and Therapy
  90. Safety and Efficacy of Low-Dose Prasugrel as Part of Triple Therapy With Aspirin and Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention ― From the TWMU-AF PCI Registry ―
    Hisao Otsuki, Junichi Yamaguchi, Takanori Kawamoto, Masafumi Yoshikawa, Suguru Ebihara, Kazuki Tanaka, Masashi Nakao, Kentaro Jujo, Hiroyuki Arashi, Yoshimi Ota et al. · 2019 · Circulation Journal
  91. Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
    Andrea Rubboli, Marco Valgimigli, Davide Capodanno, Gregory Y.H. Lip · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  92. Management of antiplatelet or anticoagulant therapy in endoscopy: A review of literature
    Marcello Fabio Maida, Sandro Sferrazza, Carlo Domenico Maida, Gaetano Cristian Morreale, Alessandro Vitello, Giovanni Longo, Vincenzo Garofalo, Emanuele Sinagra · 2020 · World Journal of Gastrointestinal Endoscopy
  93. Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
    Renad Altoukhi, Reema A. Alshouimi, Shahad M. Al Rammah, Mohammed Alzahrani, Abdulaali R. Almutairi, Abdulmajeed M. Alshehri, Osamah M. Alfayez, Majed S. Al Yami, Omar A. Almohammed · 2020 · BMJ Open
  94. Left Atrial Appendage Closure
    ALBERT C. LIN, Bradley P. Knight · 2015 · Progress in Cardiovascular Diseases
  95. Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trial
    Min Soo Cho, Do‐Yoon Kang, Yong‐Seog Oh, Chang Hoon Lee, Eue‐Keun Choi, Ji Hyun Lee, Chang Hee Kwon, Gyung‐Min Park, Hyun Woo Park, Kyoung‐Ha Park et al. · 2022 · American Heart Journal
  96. Prognostic Impact of a History of Cancer and Atrial Fibrillation in Antithrombotic Therapy for Chronic Heart Failure
    Kotaro Nochioka, Satoshi Yasuda, Yasuhiko Sakata, Takashi Shiroto, Hideka Hayashi, JUN C. TAKAHASHI, Hiroyuki Takahama, Satoshi Miyata, Hiroaki Shimokawa · 2022 · ESC Heart Failure
  97. Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarction
    Sissel Johanne Godtfredsen, Kristian Hay Kragholm, Anna Meta Dyrvig Kristensen, Tarek Bekfani, Rikke Sørensen, Maurizio Sessa, Christian Tobias Torp-Pedersen, Deepak L. Bhatt, Manan Pareek · 2023 · European Heart Journal Open
  98. Left Atrial Appendage Closure for Stroke Prevention
    Sandia Iskandar, James L. Vacek, Madhav Lavu, Dhanunjaya Lakkireddy · 2016 · Cardiology Clinics
  99. Bleeding events attributable to concurrent use of warfarin and other medications in high-risk elderly: meta-analysis and Italian population-based investigation
    on behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE), Rosanna Irene Comoretto, Federico Rea, Ersilia Lucenteforte, Alessandro Mugelli, Gianluca Trifirò, Silvia Cascini, Giuseppe Roberto, Alessandro Chinellato, Amelia Filippelli et al. · 2018 · European Journal of Clinical Pharmacology
  100. The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly
    Leonardo Bencivenga, Klara Komici, Graziamaria Corbi, Antonio Cittadini, Nicola Ferrara, Giuseppe Rengo · 2018 · Frontiers in Physiology